Of Mice and Monkeys: Can Animal Models Be Utilized to Study Neurological Consequences of Pediatric HIV-1 Infection?

ACS Chemical Neuroscience

Volumn 6, Issue 8, 2015, Pages 1276-1289

  Carryl, Heather ^a   Swang, Melanie ^b   Lawrence, Jerome ^b   Curtis, Kimberly ^a   Kamboj, Herman ^a   Van Rompay, Koen K A ^c   De Paris, Kristina ^d   Burke, Mark W ^a  

^a HOWARD UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b HOWARD UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

animal models; hippocampus; human immunodeficiency virus 1; myelin; neurological impairments; Pediatric; simian immunodeficiency virus; stereology

Indexed keywords

VIRUS PROTEIN;

EXPERIMENTAL MODEL; HOMOLOGICAL VALIDITY; HOST; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; LATENT PERIOD; MECHANISTIC VALIDITY; NEUROIMAGING; NEUROLOGIC DISEASE; NEUROPATHOLOGY; NEUROTOXICOLOGY; NONHUMAN; PATHOGENIC VALIDITY; PREDICTIVE VALIDITY; PRIMATE MODEL; PRIORITY JOURNAL; REVIEW; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME; VALIDITY; ANIMAL; CHILD; DISEASE MODEL; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PATHOLOGY; PATHOPHYSIOLOGY;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA; MUS; PRIMATES; RATTUS; RODENTIA; SIMIAN IMMUNODEFICIENCY VIRUS;

ANIMALS; CHILD; DISEASE MODELS, ANIMAL; HIV INFECTIONS; HIV-1; HUMANS; SIMIAN ACQUIRED IMMUNODEFICIENCY SYNDROME;

EID: 84939781588     PISSN: None     EISSN: 19487193     Source Type: Journal    
DOI: 10.1021/acschemneuro.5b00044     Document Type: Review

References (194)

1. United Nations (2000) United Nations Millennium Declaration, United Nations General Assembly, New York.
2. UNAIDS (2013) Global Report UNAIDS report on the global AIDS epidemic 2013, pp 1-198, Joint United Nations Programme on HIV/AIDS (UNAIDS), Geneva.
3. WHO (2006) Taking stock: HIV in children, World Health Organization, Geneva.
4. UNAIDS. ((2010) It takes a village: Ending mother-to-child transmission a partnership uniting the Millennium Villages Project and UNAIDS, http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/document/2010/20101231-MVP-en.pdf
5. UNAIDS (2010) Children and AIDS fifth Stocktaking report, 2010; http://www.unaids.org/en/targetsandcommitments/eliminatingnewhivinfectionamongchildren/ (UNICEF/UNAIDS/WHO/UNFPA, Ed.).
6. UNAIDS.((2014) UNAIDS Fact Sheet 2014, UNAIDS, Geneva.
7. Lane, J. H., Tarantal, A. F., Pauley, D., Marthas, M., Miller, C. J., and Lackner, A. A. (1996) Localization of simian immunodeficiency virus nucleic acid and antigen in brains of fetal macaques inoculated in utero Am. J. Pathol. 149, 1097-1104
8. Luzuriaga, K., Newell, M. L., Dabis, F., Excler, J. L., and Sullivan, J. L. (2006) Vaccines to prevent transmission of HIV-1 via breastmilk: Scientific and logistical priorities Lancet 368, 511-521
9. Becquet, R., Marston, M., Dabis, F., Moulton, L. H., Gray, G., Coovadia, H. M., Essex, M., Ekouevi, D. K., Jackson, D., Coutsoudis, A., Kilewo, C., Leroy, V., Wiktor, S. Z., Nduati, R., Msellati, P., Zaba, B., Ghys, P. D., and Newell, M. L. (2012) Children who acquire HIV infection perinatally are at higher risk of early death than those acquiring infection through breastmilk: A meta-analysis PLoS One 7, e28510
10. Rollins, N., Mahy, M., Becquet, R., Kuhn, L., Creek, T., and Mofenson, L. (2012) Estimates of peripartum and postnatal mother-to-child transmission probabilities of HIV for use in Spectrum and other population-based models Sex Transm. Infect. 88 (Suppl 2) i44-51
11. Kaul, M. (2008) HIV's double strike at the brain: Neuronal toxicity and compromised neurogenesis Front. Biosci. 13, 2484-2494
12. Brady, M. T., Oleske, J. M., Williams, P. L., Elgie, C., Mofenson, L. M., Dankner, W. M., and Van Dyke, R. B. (2010) Declines in mortality rates and changes in causes of death in HIV-1-infected children during the HAART era J. Acquired Immune Defic. Syndr. 53, 86-94
13. Mofenson, L. M. and Cotton, M. F. (2013) The challenges of success: Adolescents with perinatal HIV infection J. Int. AIDS Soc. 16, 18650
14. Desai, N., Mullen, P., and Mathur, M. (2008) Lipodystrophy in pediatric HIV Indian J. Pediatr. 75, 351-354
15. Cohen, S., Smit, C., van Rossum, A. M., Fraaij, P. L., Wolfs, T. F., Geelen, S. P., Scholvinck, E. H., Warris, A., Scherpbier, H. J., and Pajkrt, D. (2013) Long-term response to combination antiretroviral therapy in HIV-infected children in the Netherlands registered from 1996 to 2012 AIDS 27, 2567-2575
16. Nations, U. (2014) The Millennium Development Goals Report, (Too-Kong, T., Ed.), United Nations, New York.
17. CDC (2006) Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005 MMWR Morb. Mortal. Wkly Rep. 55, 592-597
18. Lu, D., Liu, J., Samson, L., Bitnun, A., Seigel, S., Brophy, J., Leonard, L., and Remis, R. S. (2014) Factors responsible for mother-to-child HIV transmission in Ontario, Canada, 1996-2008 Can. J. Public Health 105, e47-52
19. CDC.((2014) HIV Among Pregnant Women, Infants, and Children, http://www.cdc.gov/hiv/risk/gender/pregnantwomen/facts/index.html.
20. Dowshen, N. and D'Angelo, L. (2011) Health care transition for youth living with HIV/AIDS Pediatrics 128, 762-771
21. Sohn, A. H. and Hazra, R. (2013) The changing epidemiology of the global paediatric HIV epidemic: keeping track of perinatally HIV-infected adolescents J. Int. AIDS Soc. 16, 18555
22. Heidari, S., Mofenson, L. M., Hobbs, C. V., Cotton, M. F., Marlink, R., and Katabira, E. (2012) Unresolved antiretroviral treatment management issues in HIV-infected children J. Acquired Immune Defic. Syndr. 59, 161-169
23. Hazra, R., Siberry, G. K., and Mofenson, L. M. (2010) Growing up with HIV: Children, adolescents, and young adults with perinatally acquired HIV infection Annu. Rev. Med. 61, 169-185
24. MacDonell, K., Naar-King, S., Huszti, H., and Belzer, M. (2013) Barriers to medication adherence in behaviorally and perinatally infected youth living with HIV AIDS Behav. 17, 86-93
25. Somarriba, G., Lopez-Mitnik, G., Ludwig, D. A., Neri, D., Schaefer, N., Lipshultz, S. E., Scott, G. B., and Miller, T. L. (2013) Physical fitness in children infected with the human immunodeficiency virus: Associations with highly active antiretroviral therapy AIDS Res. Hum. Retroviruses 29, 112-120
26. Patel, K., Wang, J., Jacobson, D. L., Lipshultz, S. E., Landy, D. C., Geffner, M. E., Dimeglio, L. A., Seage, G. R., 3rd, Williams, P. L., Van Dyke, R. B., Siberry, G. K., Shearer, W. T., Young, L., Scott, G. B., Wilkinson, J. D., Fisher, S. D., Starc, T. J., and Miller, T. L. (2014) Aggregate risk of cardiovascular disease among adolescents perinatally infected with the human immunodeficiency virus Circulation 129, 1204-1212
27. Lipshultz, S. E., Miller, T. L., Wilkinson, J. D., Scott, G. B., Somarriba, G., Cochran, T. R., and Fisher, S. D. (2013) Cardiac effects in perinatally HIV-infected and HIV-exposed but uninfected children and adolescents: a view from the United States of America J. Int. AIDS Soc. 16, 18597
28. Lipshultz, S. E., Williams, P. L., Wilkinson, J. D., Leister, E. C., Van Dyke, R. B., Shearer, W. T., Rich, K. C., Hazra, R., Kaltman, J. R., Jacobson, D. L., Dooley, L. B., Scott, G. B., Rabideau, N., and Colan, S. D. (2013) Cardiac status of children infected with human immunodeficiency virus who are receiving long-term combination antiretroviral therapy: Results from the Adolescent Master Protocol of the Multicenter Pediatric HIV/AIDS Cohort Study JAMA Pediatr. 167, 520-527
29. Barlow-Mosha, L., Eckard, A. R., McComsey, G. A., and Musoke, P. M. (2013) Metabolic complications and treatment of perinatally HIV-infected children and adolescents J. Int. AIDS Soc. 16, 18600
30. Bisiacchi, P. S., Suppiej, A., and Laverda, A. (2000) Neuropsychological evaluation of neurologically asymptomatic HIV-infected children Brain Cognit. 43, 49-52
31. Smith, R. J. (2006) Adherence to antiretroviral HIV drugs: How many doses can you miss before resistance emerges? Proc. Biol. Sci. 273, 617-624
32. Smith, R., Malee, K., Leighty, R., Brouwers, P., Mellins, C., Hittelman, J., Chase, C., and Blasini, I. (2006) Effects of perinatal HIV infection and associated risk factors on cognitive development among young children Pediatrics 117, 851-862
33. Kapetanovic, S., Leister, E., Nichols, S., Miller, T., Tassiopoulos, K., Hazra, R., Gelbard, H. A., Malee, K. M., Kammerer, B., Mendez, A. J., and Williams, P. L. (2010) Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth AIDS 24, 1481-1491
34. Foster, S. B., Lu, M., Glaze, D. G., Reuben, J. M., Harris, L. L., Cohen, E. N., Lee, B. N., Zhao, E., Paul, M. E., Schwarzwald, H., McMullen-Jackson, C., Clark, C., Armstrong, F. D., Brouwers, P. Y., Miller, T. L., Colin, A. A., Scott, G. B., Shahzeidi, S., Willen, E. J., Asthana, D., Lipshultz, S. E., Thompson, B. W., and Shearer, W. T. (2012) Associations of cytokines, sleep patterns, and neurocognitive function in youth with HIV infection Clin. Immunol. 144, 13-23
35. Walker, S. Y., Pierre, R. B., Christie, C. D., and Chang, S. M. (2013) Neurocognitive function in HIV-positive children in a developing country Int. J. Infect. Dis. 17, e862-867
36. Laughton, B., Cornell, M., Boivin, M., and Van Rie, A. (2013) Neurodevelopment in perinatally HIV-infected children: a concern for adolescence J. Int. AIDS Soc. 16, 18603
37. Gadow, K. D., Angelidou, K., Chernoff, M., Williams, P. L., Heston, J., Hodge, J., and Nachman, S. (2012) Longitudinal study of emerging mental health concerns in youth perinatally infected with HIV and peer comparisons J. Dev. Behav. Pediatr. 33, 456-468
38. Govender, R., Eley, B., Walker, K., Petersen, R., and Wilmshurst, J. M. (2011) Neurologic and neurobehavioral sequelae in children with human immunodeficiency virus (HIV-1) infection J. Child Neurol. 26, 1355-1364
39. Lindl, K. A., Marks, D. R., Kolson, D. L., and Jordan-Sciutto, K. L. (2010) HIV-associated neurocognitive disorder: Pathogenesis and therapeutic opportunities J. Neuroimmune Pharmacol. 5, 294-309
40. Van Rie, A., Harrington, P. R., Dow, A., and Robertson, K. (2007) Neurologic and neurodevelopmental manifestations of pediatric HIV/AIDS: a global perspective Eur. J. Paediatr. Neurol. 11, 1-9
41. Pearson, D. A., McGrath, N. M., Nozyce, M., Nichols, S. L., Raskino, C., Brouwers, P., Lifschitz, M. C., Baker, C. J., and Englund, J. A. (2000) Predicting HIV disease progression in children using measures of neuropsychological and neurological functioning. Pediatric AIDS clinical trials 152 study team Pediatrics 106, E76
42. UNAIDS (2013) Global Report: UNAIDS report on the global AIDS epidemic 2013, UNAIDS, Geneva.
43. van Arnhem, L. A., Bunders, M. J., Scherpbier, H. J., Majoie, C. B., Reneman, L., Frinking, O., Poll-The, B. T., Kuijpers, T. W., and Pajkrt, D. (2013) Neurologic abnormalities in HIV-1 infected children in the era of combination antiretroviral therapy PLoS One 8, e64398
44. Donald, K. A., Hoare, J., Eley, B., and Wilmshurst, J. M. (2014) Neurologic complications of pediatric human immunodeficiency virus: implications for clinical practice and management challenges in the African setting Semin. Pediatr. Neurol. 21, 3-11
45. Foster, C. J., Biggs, R. L., Melvin, D., Walters, M. D., Tudor-Williams, G., and Lyall, E. G. (2006) Neurodevelopmental outcomes in children with HIV infection under 3 years of age Dev. Med. Child Neurol. 48, 677-682
46. Crowell, C. S., Malee, K. M., Yogev, R., and Muller, W. J. (2014) Neurologic disease in HIV-infected children and the impact of combination antiretroviral therapy Rev. Med. Virol. 24, 316-331
47. Lowick, S., Sawry, S., and Meyers, T. (2012) Neurodevelopmental delay among HIV-infected preschool children receiving antiretroviral therapy and healthy preschool children in Soweto, South Africa Psychol. Health Med. 17, 599-610
48. Whitehead, N., Potterton, J., and Coovadia, A. (2014) The neurodevelopment of HIV-infected infants on HAART compared to HIV-exposed but uninfected infants AIDS Care 26, 497-504
49. Cohen, S., Ter Stege, J. A., Geurtsen, G. J., Scherpbier, H. J., Kuijpers, T. W., Reiss, P., Schmand, B., and Pajkrt, D. (2015) Poorer cognitive performance in perinatally HIV-infected children as compared to healthy socioeconomically matched controls Clin. Infect.Dis. 60, 1111-1119
50. Ferguson, G. and Jelsma, J. (2009) The prevalence of motor delay among HIV infected children living in Cape Town, South Africa Int. J. Rehabil. Res. 32, 108-114
51. Thomaidis, L., Bertou, G., Critselis, E., Spoulou, V., Kafetzis, D. A., and Theodoridou, M. (2010) Cognitive and psychosocial development of HIV pediatric patients receiving highly active anti-retroviral therapy: a case-control study BMC Pediatr. 10, 99
52. Blanchette, N., Smith, M. L., King, S., Fernandes-Penney, A., and Read, S. (2002) Cognitive development in school-age children with vertically transmitted HIV infection Dev. Neuropsychol. 21, 223-241
53. Woods, S. P., Moore, D. J., Weber, E., and Grant, I. (2009) Cognitive neuropsychology of HIV-associated neurocognitive disorders Neuropsychol. Rev. 19, 152-168
54. Puthanakit, T., Ananworanich, J., Vonthanak, S., Kosalaraksa, P., Hansudewechakul, R., van der Lugt, J., Kerr, S. J., Kanjanavanit, S., Ngampiyaskul, C., Wongsawat, J., Luesomboon, W., Vibol, U., Pruksakaew, K., Suwarnlerk, T., Apornpong, T., Ratanadilok, K., Paul, R., Mofenson, L. M., Fox, L., Valcour, V., Brouwers, P., and Ruxrungtham, K. (2013) Cognitive function and neurodevelopmental outcomes in HIV-infected Children older than 1 year of age randomized to early versus deferred antiretroviral therapy: the PREDICT neurodevelopmental study Pediatr. Infect. Dis J. 32, 501-508
55. Puthanakit, T., Aurpibul, L., Louthrenoo, O., Tapanya, P., Nadsasarn, R., Insee-ard, S., and Sirisanthana, V. (2010) Poor cognitive functioning of school-aged children in thailand with perinatally acquired HIV infection taking antiretroviral therapy AIDS Patient Care STDS 24, 141-146
56. Hoare, J., Fouche, J. P., Spottiswoode, B., Donald, K., Philipps, N., Bezuidenhout, H., Mulligan, C., Webster, V., Oduro, C., Schrieff, L., Paul, R., Zar, H., Thomas, K., and Stein, D. (2012) A diffusion tensor imaging and neurocognitive study of HIV-positive children who are HAART-naive "slow progressors" J. Neurovirol. 18, 205-212
57. Samia, P., Petersen, R., Walker, K. G., Eley, B., and Wilmshurst, J. M. (2013) Prevalence of seizures in children infected with human immunodeficiency virus J. Child Neurol. 28, 297-302
58. Facchini, S. A., Harding, S. A., and Waldron, R. L. (2002) Human immunodeficiency virus-1 infection and multiple sclerosis-like illness in a child Pediatr. Neurol. 26, 231-235
59. Nozyce, M. L., Lee, S. S., Wiznia, A., Nachman, S., Mofenson, L. M., Smith, M. E., Yogev, R., McIntosh, K., Stanley, K., and Pelton, S. (2006) A behavioral and cognitive profile of clinically stable HIV-infected children Pediatrics 117, 763-770
60. Singh, K. K., Ellis, R. J., Marquie-Beck, J., Letendre, S., Heaton, R. K., Grant, I., and Spector, S. A. (2004) CCR2 polymorphisms affect neuropsychological impairment in HIV-1-infected adults J. Neuroimmunol. 157, 185-192
61. Fraser, C., Lythgoe, K., Leventhal, G. E., Shirreff, G., Hollingsworth, T. D., Alizon, S., and Bonhoeffer, S. (2014) Virulence and pathogenesis of HIV-1 infection: an evolutionary perspective Science 343, 1243727
62. Geretti, A. M. (2006) HIV-1 subtypes: epidemiology and significance for HIV management Curr. Opin. Infect. Dis. 19, 1-7
63. Siddappa, N. B., Dash, P. K., Mahadevan, A., Jayasuryan, N., Hu, F., Dice, B., Keefe, R., Satish, K. S., Satish, B., Sreekanthan, K., Chatterjee, R., Venu, K., Satishchandra, P., Ravi, V., Shankar, S. K., Shankarappa, R., and Ranga, U. (2004) Identification of subtype C human immunodeficiency virus type 1 by subtype-specific PCR and its use in the characterization of viruses circulating in the southern parts of India J. Clin. Microbiol. 42, 2742-2751
64. Campbell, G. R., Loret, E. P., and Spector, S. A. (2010) HIV-1 clade B Tat, but not clade C Tat, increases X4 HIV-1 entry into resting but not activated CD4+ T cells J. Biol. Chem. 285, 1681-1691
65. Mishra, M., Vetrivel, S., Siddappa, N. B., Ranga, U., and Seth, P. (2008) Clade-specific differences in neurotoxicity of human immunodeficiency virus-1 B and C Tat of human neurons: significance of dicysteine C30C31 motif Ann. Neurol. 63, 366-376
66. Shankar, S. K., Mahadevan, A., Satishchandra, P., Kumar, R. U., Yasha, T. C., Santosh, V., Chandramuki, A., Ravi, V., and Nath, A. (2005) Neuropathology of HIV/AIDS with an overview of the Indian scene Indian J. Med. Res. 121, 468-488
67. Mishra, V., Assche, S. B., Greener, R., Vaessen, M., Hong, R., Ghys, P. D., Boerma, J. T., Van Assche, A., Khan, S., and Rutstein, S. (2007) HIV infection does not disproportionately affect the poorer in sub-Saharan Africa AIDS 21 (Suppl 7) S17-28
68. Rao, V. R., Sas, A. R., Eugenin, E. A., Siddappa, N. B., Bimonte-Nelson, H., Berman, J. W., Ranga, U., Tyor, W. R., and Prasad, V. R. (2008) HIV-1 clade-specific differences in the induction of neuropathogenesis J. Neurosci. 28, 10010-10016
69. Wong, J. K., Campbell, G. R., and Spector, S. A. (2010) Differential induction of interleukin-10 in monocytes by HIV-1 clade B and clade C Tat proteins J. Biol. Chem. 285, 18319-18325
70. Campbell, G. R., Watkins, J. D., Loret, E. P., and Spector, S. A. (2011) Differential induction of rat neuronal excitotoxic cell death by human immunodeficiency virus type 1 clade B and C tat proteins AIDS Res. Hum. Retroviruses 27, 647-654
71. Msellati, P., Lepage, P., Hitimana, D. G., Van Goethem, C., Van de Perre, P., and Dabis, F. (1993) Neurodevelopmental testing of children born to human immunodeficiency virus type 1 seropositive and seronegative mothers: a prospective cohort study in Kigali, Rwanda Pediatrics 92, 843-848
72. Boivin, M. J., Green, S. D., Davies, A. G., Giordani, B., Mokili, J. K., and Cutting, W. A. (1995) A preliminary evaluation of the cognitive and motor effects of pediatric HIV infection in Zairian children Health Psychol. 14, 13-21
73. Bagenda, D., Nassali, A., Kalyesubula, I., Sherman, B., Drotar, D., Boivin, M. J., and Olness, K. (2006) Health, neurologic, and cognitive status of HIV-infected, long-surviving, and antiretroviral-naive Ugandan children Pediatrics 117, 729-740
74. McGrath, N., Bellinger, D., Robins, J., Msamanga, G. I., Tronick, E., and Fawzi, W. W. (2006) Effect of maternal multivitamin supplementation on the mental and psychomotor development of children who are born to HIV-1-infected mothers in Tanzania Pediatrics 117, e216-225
75. Drotar, D., Olness, K., Wiznitzer, M., Schatschneider, C., Marum, L., Guay, L., Fagan, J., Hom, D., Svilar, G., Ndugwa, C., and Mayengo, R. K. (1999) Neurodevelopmental outcomes of Ugandan infants with HIV infection: An application of growth curve analysis Health Psychol. 18, 114-121
76. Wilmshurst, J. M., Donald, K. A., and Eley, B. (2014) Update on the key developments of the neurologic complications in children infected with HIV Curr. Opin. HIV AIDS 9, 533-538
77. Jeremy, R. J., Kim, S., Nozyce, M., Nachman, S., McIntosh, K., Pelton, S. I., Yogev, R., Wiznia, A., Johnson, G. M., Krogstad, P., and Stanley, K. (2005) Neuropsychological functioning and viral load in stable antiretroviral therapy-experienced HIV-infected children Pediatrics 115, 380-387
78. Zink, W. E., Zheng, J., Persidsky, Y., Poluektova, L., and Gendelman, H. E. (1999) The neuropathogenesis of HIV-1 infection FEMS Immunol. Med. Microbiol. 26, 233-241
79. Johann-Liang, R., Lin, K., Cervia, J., Stavola, J., and Noel, G. (1998) Neuroimaging findings in children perinatally infected with the human immunodeficiency virus Pediatr. Infect. Dis. J. 17, 753-754
80. Chiriboga, C. A., Fleishman, S., Champion, S., Gaye-Robinson, L., and Abrams, E. J. (2005) Incidence and prevalence of HIV encephalopathy in children with HIV infection receiving highly active anti-retroviral therapy (HAART) J. Pediatr. 146, 402-407
81. Tahan, T. T., Bruck, I., Burger, M., and Cruz, C. R. (2006) Neurological profile and neurodevelopment of 88 children infected with HIV and 84 seroreverter children followed from 1995 to 2002 Braz. J. Infect. Dis. 10, 322-326
82. Sarma, M. K., Nagarajan, R., Keller, M. A., Kumar, R., Nielsen-Saines, K., Michalik, D. E., Deville, J., Church, J. A., and Thomas, M. A. (2014) Regional brain gray and white matter changes in perinatally HIV-infected adolescents NeuroImage: Clin. 4, 29-34
83. Van Rie, A., Mupuala, A., and Dow, A. (2008) Impact of the HIV/AIDS epidemic on the neurodevelopment of preschool-aged children in Kinshasa, Democratic Republic of the Congo Pediatrics 122, e123-128
84. Nagarajan, R., Sarma, M. K., Thomas, M. A., Chang, L., Natha, U., Wright, M., Hayes, J., Nielsen-Saines, K., Michalik, D. E., Deville, J., Church, J. A., Mason, K., Critton-Mastandrea, T., Nazarian, S., Jing, J., and Keller, M. A. (2012) Neuropsychological function and cerebral metabolites in HIV-infected youth J. Neuroimmune Pharmacol. 7, 981-990
85. Ackermann, C., Andronikou, S., Laughton, B., Kidd, M., Dobbels, E., Innes, S., van Toorn, R., and Cotton, M. (2014) White matter signal abnormalities in children with suspected HIV-related neurologic disease on early combination antiretroviral therapy Pediatr. Infect. Dis. J. 33, e207-212
86. Patsalides, A. D., Wood, L. V., Atac, G. K., Sandifer, E., Butman, J. A., and Patronas, N. J. (2002) Cerebrovascular disease in HIV-infected pediatric patients: neuroimaging findings AJR Am. J. Roentgenol 179, 999-1003
87. Blumberg, B. M., Gelbard, H. A., and Epstein, L. G. (1994) HIV-1 infection of the developing nervous system: central role of astrocytes in pathogenesis Virus Res. 32, 253-267
88. Tornatore, C., Chandra, R., Berger, J. R., and Major, E. O. (1994) HIV-1 infection of subcortical astrocytes in the pediatric central nervous system Neurology 44, 481-487
89. Gelbard, H. A., James, H. J., Sharer, L. R., Perry, S. W., Saito, Y., Kazee, A. M., Blumberg, B. M., and Epstein, L. G. (1995) Apoptotic neurons in brains from paediatric patients with HIV-1 encephalitis and progressive encephalopathy Neuropathol Appl. Neurobiol. 21, 208-217
90. Canto-Nogues, C., Sanchez-Ramon, S., Alvarez, S., Lacruz, C., and Munoz-Fernandez, M. A. (2005) HIV-1 infection of neurons might account for progressive HIV-1-associated encephalopathy in children J. Mol. Neurosci. 27, 79-89
91. George, R., Andronikou, S., du Plessis, J., du Plessis, A. M., Van Toorn, R., and Maydell, A. (2009) Central nervous system manifestations of HIV infection in children Pediatr. Radiol. 39, 575-585
92. Sattler, F., He, J., Letendre, S., Wilson, C., Sanders, C., Heaton, R. K., Ellis, R. J., Franklin, D., Grant, I., and McCutchan, J. A. (2014) Abdominal obesity, inflammation, immune activation and neurocognitive impairment. Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, MA.
93. Piazza, F., Astori, M. G., Maccabruni, A., Caselli, D., Bossi, G., and Lanzi, G. (1995) [Neuropsychological development of children born to HIV-positive mothers] Pediatr. Med. Chir 17, 331-333
94. Bruck, I., Tahan, T. T., Cruz, C. R., Martins, L. T., Antoniuk, S. A., Rodrigues, M., Souza, S. M., and Bruyn, L. R. (2001) Developmental milestones of vertically HIV infected and seroreverters children: follow up of 83 children Arq. Neuro-Psiquiatr. 59, 691-695
95. Blanchette, N., Smith, M. L., Fernandes-Penney, A., King, S., and Read, S. (2001) Cognitive and motor development in children with vertically transmitted HIV infection Brain Cogn. 46, 50-53
96. Poirier, M. C., Gibbons, A. T., Rugeles, M. T., Andre-Schmutz, I., and Blanche, S. (2015) Fetal consequences of maternal antiretroviral nucleoside reverse transcriptase inhibitor use in human and nonhuman primate pregnancy Curr. Opin. Pediatr. 27, 233-239
97. Tardieu, M., Brunelle, F., Raybaud, C., Ball, W., Barret, B., Pautard, B., Lachassine, E., Mayaux, M. J., and Blanche, S. (2005) Cerebral MR imaging in uninfected children born to HIV-seropositive mothers and perinatally exposed to zidovudine AJNR Am. J. Neuroradiol. 26, 695-701
98. Barret, B., Tardieu, M., Rustin, P., Lacroix, C., Chabrol, B., Desguerre, I., Dollfus, C., Mayaux, M. J., Blanche, S., and French Perinatal Cohort Study, G. (2003) Persistent mitochondrial dysfunction in HIV-1-exposed but uninfected infants: clinical screening in a large prospective cohort AIDS 17, 1769-1785
99. Selvam, A., Buhimschi, I., Makin, J., Pattinson, R., Anderson, R., and Forsyth, B. (2015) Hyperferritinemia and markers of inflammation and oxidative stress in the cord blood of HIV-exposed, uninfected (HEU) infants HIV Med. 10.1111/hiv.12214
100. Chan, D. C. and Kim, P. S. (1998) HIV entry and its inhibition Cell 93, 681-684
101. Nischang, M., Gers-Huber, G., Audige, A., Akkina, R., and Speck, R. F. (2012) Modeling HIV infection and therapies in humanized mice Swiss Med. Wkly. 142, w13618
102. Bagashev, A. and Sawaya, B. E. (2013) Roles and functions of HIV-1 Tat protein in the CNS: an overview Virol J. 10, 358
103. Tran, P. B. and Miller, R. J. (2005) HIV-1, chemokines and neurogenesis Neurotoxic. Res. 8, 149-158
104. Lee, M. H., Wang, T., Jang, M. H., Steiner, J., Haughey, N., Ming, G. L., Song, H., Nath, A., and Venkatesan, A. (2011) Rescue of adult hippocampal neurogenesis in a mouse model of HIV neurologic disease Neurobiol. Dis. 41, 678-687
105. Lee, M. H., Amin, N. D., Venkatesan, A., Wang, T., Tyagi, R., Pant, H. C., and Nath, A. (2013) Impaired neurogenesis and neurite outgrowth in an HIV-gp120 transgenic model is reversed by exercise via BDNF production and Cdk5 regulation J. Neurovirol. 19, 418-431
106. Krathwohl, M. D. and Kaiser, J. L. (2004) HIV-1 promotes quiescence in human neural progenitor cells J. Infect. Dis. 190, 216-226
107. Irish, B. P., Khan, Z. K., Jain, P., Nonnemacher, M. R., Pirrone, V., Rahman, S., Rajagopalan, N., Suchitra, J. B., Mostoller, K., and Wigdahl, B. (2009) Molecular Mechanisms of Neurodegenerative Diseases Induced by Human Retroviruses: A Review Am. J. Infect. Dis. 5, 231-258
108. Engelhardt, B. and Liebner, S. (2014) Novel insights into the development and maintenance of the blood-brain barrier Cell Tissue Res. 355, 687-699
109. Liu, S., Agalliu, D., Yu, C., and Fisher, M. (2012) The role of pericytes in blood-brain barrier function and stroke Curr. Pharm. Des. 18, 3653-3662
110. Sa-Pereira, I., Brites, D., and Brito, M. A. (2012) Neurovascular unit: a focus on pericytes Mol. Neurobiol. 45, 327-347
111. Khan, N. A., Di Cello, F., Stins, M., and Kim, K. S. (2007) Gp120-mediated cytotoxicity of human brain microvascular endothelial cells is dependent on p38 mitogen-activated protein kinase activation J. Neurovirol. 13, 242-251
112. Khan, N. A., Di Cello, F., Nath, A., and Kim, K. S. (2003) Human immunodeficiency virus type 1 tat-mediated cytotoxicity of human brain microvascular endothelial cells J. Neurovirol. 9, 584-593
113. Shiu, C., Barbier, E., Di Cello, F., Choi, H. J., and Stins, M. (2007) HIV-1 gp120 as well as alcohol affect blood-brain barrier permeability and stress fiber formation: involvement of reactive oxygen species Alcohol.: Clin. Exp. Res. 31, 130-137
114. Stins, M. F., Pearce, D., Choi, H., Di Cello, F., Pardo, C. A., and Kim, K. S. (2004) CD4 and chemokine receptors on human brain microvascular endothelial cells, implications for human immunodeficiency virus type 1 pathogenesis Endothelium 11, 275-284
115. Wang, H., Sun, J., and Goldstein, H. (2008) Human immunodeficiency virus type 1 infection increases the in vivo capacity of peripheral monocytes to cross the blood-brain barrier into the brain and the in vivo sensitivity of the blood-brain barrier to disruption by lipopolysaccharide J. Virol. 82, 7591-7600
116. Westmoreland, S. V., Alvarez, X., deBakker, C., Aye, P., Wilson, M. L., Williams, K. C., and Lackner, A. A. (2002) Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain J. Neuroimmunol. 122, 146-158
117. Shepherd, A. J., Loo, L., Gupte, R. P., Mickle, A. D., and Mohapatra, D. P. (2012) Distinct modifications in Kv2.1 channel via chemokine receptor CXCR4 regulate neuronal survival-death dynamics J. Neurosci. 32, 17725-17739
118. Kaul, M. (2009) HIV-1 associated dementia: update on pathological mechanisms and therapeutic approaches Curr. Opin. Neurol. 22, 315-320
119. Medders, K. E. and Kaul, M. (2011) Mitogen-activated protein kinase p38 in HIV infection and associated brain injury J. Neuroimmune Pharmacol. 6, 202-215
120. Rodriguez-Franco, E. J., Cantres-Rosario, Y. M., Plaud-Valentin, M., Romeu, R., Rodriguez, Y., Skolasky, R., Melendez, V., Cadilla, C. L., and Melendez, L. M. (2012) Dysregulation of macrophage-secreted cathepsin B contributes to HIV-1-linked neuronal apoptosis PLoS One 7, e36571
121. Das, S. and Basu, A. (2011) Viral infection and neural stem/progenitor cell's fate: Implications in brain development and neurological disorders Neurochem. Int. 59, 357-366
122. Abel, K. (2009) The rhesus macaque pediatric SIV infection model-A valuable tool in understanding infant HIV-1 pathogenesis and for designing pediatric HIV-1 prevention strategies Curr. HIV Res. 7, 2-11
123. McClure, H. M., Anderson, D. C., Ansari, A. A., and Klumpp, S. A. (1992) The simian immunodeficiency virus infected macaque: a model for pediatric AIDS Pathol. Biol. 40, 694-700
124. Fitting, S., Booze, R. M., Hasselrot, U., and Mactutus, C. F. (2010) Dose-dependent long-term effects of Tat in the rat hippocampal formation: a design-based stereological study Hippocampus 20, 469-480
125. Van Rompay, K. K., Kearney, B. P., Sexton, J. J., Colon, R., Lawson, J. R., Blackwood, E. J., Lee, W. A., Bischofberger, N., and Marthas, M. L. (2006) Evaluation of oral tenofovir disoproxil fumarate and topical tenofovir GS-7340 to protect infant macaques against repeated oral challenges with virulent simian immunodeficiency virus J. Acquired Immune Defic. Syndr. 43, 6-14
126. Abel, K., Pahar, B., Van Rompay, K. K., Fritts, L., Sin, C., Schmidt, K., Colon, R., McChesney, M., and Marthas, M. L. (2006) Rapid virus dissemination in infant macaques after oral simian immunodeficiency virus exposure in the presence of local innate immune responses J. Virol. 80, 6357-6367
127. Ranganathan, U. D., Larsen, M. H., Kim, J., Porcelli, S. A., Jacobs, W. R., Jr., and Fennelly, G. J. (2009) Recombinant pro-apoptotic Mycobacterium tuberculosis generates CD8+ T cell responses against human immunodeficiency virus type 1 Env and M. tuberculosis in neonatal mice Vaccine 28, 152-161
128. Westmoreland, S. V., Williams, K. C., Simon, M. A., Bahn, M. E., Rullkoetter, A. E., Elliott, M. W., deBakker, C. D., Knight, H. L., and Lackner, A. A. (1999) Neuropathogenesis of simian immunodeficiency virus in neonatal rhesus macaques Am. J. Pathol. 155, 1217-1228
129. Baba, T. W., Jeong, Y. S., Pennick, D., Bronson, R., Greene, M. F., and Ruprecht, R. M. (1995) Pathogenicity of live, attenuated SIV after mucosal infection of neonatal macaques Science 267, 1820-1825
130. Bieniasz, P. D. and Cullen, B. R. (2000) Multiple blocks to human immunodeficiency virus type 1 replication in rodent cells J. Virol 74, 9868-9877
131. Burdo, T. H. and Miller, A. D. (2014) Animal models of HIV peripheral neuropathy Future Virol. 9, 465-474
132. Fitting, S., Booze, R. M., and Mactutus, C. F. (2008) Neonatal intrahippocampal injection of the HIV-1 proteins gp120 and Tat: differential effects on behavior and the relationship to stereological hippocampal measures Brain Res. 1232, 139-154
133. Moran, L. M., Fitting, S., Booze, R. M., Webb, K. M., and Mactutus, C. F. (2014) Neonatal intrahippocampal HIV-1 protein Tat1-86 injection: neurobehavioral alterations in the absence of increased inflammatory cytokine activation Int. J. Dev. Neurosci. 38, 195-203
134. Fitting, S., Ignatowska-Jankowska, B. M., Bull, C., Skoff, R. P., Lichtman, A. H., Wise, L. E., Fox, M. A., Su, J., Medina, A. E., Krahe, T. E., Knapp, P. E., Guido, W., and Hauser, K. F. (2013) Synaptic dysfunction in the hippocampus accompanies learning and memory deficits in human immunodeficiency virus type-1 Tat transgenic mice Biol. Psychiatry 73, 443-453
135. Dash, P. K., Gorantla, S., Gendelman, H. E., Knibbe, J., Casale, G. P., Makarov, E., Epstein, A. A., Gelbard, H. A., Boska, M. D., and Poluektova, L. Y. (2011) Loss of neuronal integrity during progressive HIV-1 infection of humanized mice J. Neurosci. 31, 3148-3157
136. Gorantla, S., Makarov, E., Finke-Dwyer, J., Castanedo, A., Holguin, A., Gebhart, C. L., Gendelman, H. E., and Poluektova, L. (2010) Links between progressive HIV-1 infection of humanized mice and viral neuropathogenesis Am. J. Pathol. 177, 2938-2949
137. Fitting, S., Booze, R. M., Hasselrot, U., and Mactutus, C. F. (2008) Differential long-term neurotoxicity of HIV-1 proteins in the rat hippocampal formation: A design-based stereological study Hippocampus 18, 135-147
138. Fitting, S., Booze, R. M., and Mactutus, C. F. (2006) Neonatal hippocampal Tat injections: developmental effects on prepulse inhibition (PPI) of the auditory startle response Int. J. Dev. Neurosci. 24, 275-283
139. Hill, J. M., Mervis, R. F., Avidor, R., Moody, T. W., and Brenneman, D. E. (1993) HIV envelope protein-induced neuronal damage and retardation of behavioral development in rat neonates Brain Res. 603, 222-233
140. Fitting, S., Booze, R. M., and Mactutus, C. F. (2007) Neonatal intrahippocampal gp120 injection: an examination early in development Neurotoxicology 28, 101-107
141. Fitting, S., Booze, R. M., and Mactutus, C. F. (2006) Neonatal intrahippocampal glycoprotein 120 injection: The role of dopaminergic alterations in prepulse inhibition in adult rats J. Pharmacol. Exp. Ther. 318, 1352-1358
142. Boska, M. D., Dash, P. K., Knibbe, J., Epstein, A. A., Akhter, S. P., Fields, N., High, R., Makarov, E., Bonasera, S., Gelbard, H. A., Poluektova, L. Y., Gendelman, H. E., and Gorantla, S. (2014) Associations between brain microstructures, metabolites, and cognitive deficits during chronic HIV-1 infection of humanized mice Mol. Neurodegener. 9, 58
143. Denton, P. W. and Garcia, J. V. (2011) Humanized mouse models of HIV infection AIDS Rev. 13, 135-148
144. Li, G., Cheng, M., Nunoya, J., Cheng, L., Guo, H., Yu, H., Liu, Y. J., Su, L., and Zhang, L. (2014) Plasmacytoid dendritic cells suppress HIV-1 replication but contribute to HIV-1 induced immunopathogenesis in humanized mice PLoS Pathog. 10, e1004291
145. Berges, B. K. and Rowan, M. R. (2011) The utility of the new generation of humanized mice to study HIV-1 infection: transmission, prevention, pathogenesis, and treatment Retrovirology 8, 65
146. Marsden, M. D. and Zack, J. A. (2015) Studies of retroviral infection in humanized mice Virology 479-480C, 297-309
147. Potash, M. J., Chao, W., Bentsman, G., Paris, N., Saini, M., Nitkiewicz, J., Belem, P., Sharer, L., Brooks, A. I., and Volsky, D. J. (2005) A mouse model for study of systemic HIV-1 infection, antiviral immune responses, and neuroinvasiveness Proc. Natl. Acad. Sci. U. S. A. 102, 3760-3765
148. Sindberg, G. M., Sharma, U., Banerjee, S., Anand, V., Dutta, R., Gu, C. J., Volsky, D. J., and Roy, S. (2015) An infectious murine model for studying the systemic effects of opioids on early HIV pathogenesis in the gut J. Neuroimmune Pharmacol. 10, 74-87
149. Kelschenbach, J. L., Saini, M., Hadas, E., Gu, C. J., Chao, W., Bentsman, G., Hong, J. P., Hanke, T., Sharer, L. R., Potash, M. J., and Volsky, D. J. (2012) Mice chronically infected with chimeric HIV resist peripheral and brain superinfection: a model of protective immunity to HIV J. Neuroimmune Pharmacol. 7, 380-387
150. Clancy, B., Darlington, R. B., and Finlay, B. L. (2001) Translating developmental time across mammalian species Neuroscience 105, 7-17
151. Clements, J. E., Mankowski, J. L., Gama, L., and Zink, M. C. (2008) The accelerated simian immunodeficiency virus macaque model of human immunodeficiency virus-associated neurological disease: from mechanism to treatment J. Neurovirol. 14, 309-317
152. Petrides, M., Tomaiuolo, F., Yeterian, E. H., and Pandya, D. N. (2012) The prefrontal cortex: Comparative architectonic organization in the human and the macaque monkey brains Cortex 48, 46-57
153. Nowakowski, R. S. and Rakic, P. (1981) The site of origin and route and rate of migration of neurons to the hippocampal region of the rhesus monkey J. Comp. Neurol. 196, 129-154
154. Worlein, J. M., Leigh, J., Larsen, K., Kinman, L., Schmidt, A., Ochs, H., and Ho, R. J. (2005) Cognitive and motor deficits associated with HIV-2(287) infection in infant pigtailed macaques: a nonhuman primate model of pediatric neuro-AIDS J. Neurovirol. 11, 34-45
155. Kinman, L. M., Worlein, J. M., Leigh, J., Bielefeldt-Ohmann, H., Anderson, D. M., Hu, S. L., Morton, W. R., Anderson, B. D., and Ho, R. J. (2004) HIV in central nervous system and behavioral development: an HIV-2287 macaque model of AIDS AIDS 18, 1363-1370
156. Marthas, M. L., van Rompay, K. K., Otsyula, M., Miller, C. J., Canfield, D. R., Pedersen, N. C., and McChesney, M. B. (1995) Viral factors determine progression to AIDS in simian immunodeficiency virus-infected newborn rhesus macaques J. Virol. 69, 4198-4205
157. Curtis, K., Rollins, M., Carryl, H., Kimberley, B., Van Rompay, K. K., Abel, K., and Burke, M. W. (2014) Reduction of pyramidal and immature hippocampal neurons in pediatric simian immunodeficiency virus infection NeuroReport 25, 973-978
158. Burke, M., Zangenehpour, S., Mouton, P. R., and Ptito, M. (2009) Knowing what counts: unbiased stereology in the non-human primate brain J. Vis Exp. 10.3791/1262
159. Burke, M. W., Zangenehpour, S., and Ptito, M. (2009) Brain banking: Making the most of your research specimens J. Vis Exp. 10.3791/1260
160. Zangenehpour, S., Burke, M. W., Chaudhuri, A., and Ptito, M. (2009) Batch immunostaining for large-scale protein detection in the whole monkey brain J. Vis Exp. 10.3791/1286
161. Curtis, K., Rollins, M., Carryl, H., Bradshaw, K., Van Rompay, K., Abel, K., and Burke, M. (2014) Reduction of pyramidal and immature hippocampal neurons in pediatric simian immunodeficiency virus infection NeuroReport 25, 973-978
162. Schwartz, L., Civitello, L., Dunn-Pirio, A., Ryschkewitsch, S., Berry, E., Cavert, W., Kinzel, N., Lawrence, D. M., Hazra, R., and Major, E. O. (2007) Evidence of human immunodeficiency virus type 1 infection of nestin-positive neural progenitors in archival pediatric brain tissue J. Neurovirol. 13, 274-283
163. Schwartz, L. and Major, E. O. (2006) Neural progenitors and HIV-1-associated central nervous system disease in adults and children Curr. HIV Res. 4, 319-327
164. Mishra, M., Taneja, M., Malik, S., Khalique, H., and Seth, P. (2010) Human immunodeficiency virus type 1 Tat modulates proliferation and differentiation of human neural precursor cells: implication in NeuroAIDS J. Neurovirol. 16, 355-367
165. Miller, D. J., Duka, T., Stimpson, C. D., Schapiro, S. J., Baze, W. B., McArthur, M. J., Fobbs, A. J., Sousa, A. M., Sestan, N., Wildman, D. E., Lipovich, L., Kuzawa, C. W., Hof, P. R., and Sherwood, C. C. (2012) Prolonged myelination in human neocortical evolution Proc. Natl. Acad. Sci. U. S. A. 109, 16480-16485
166. Kamboj, H., Curtis, K., Carryl, H., Agyemang, H., Van Rompay, K., Abel, K., and Burke, M. (2014) Central nervous system demylenation in pediatric SIV infection. Conference on Retroviruses and Opportunistic Infections, March 3-6, 2014, Boston, MA.
167. Yamada, E., Yoshikawa, R., Nakano, Y., Misawa, N., Koyanagi, Y., and Sato, K. (2015) Impacts of humanized mouse models on the investigation of HIV-1 infection: illuminating the roles of viral accessory proteins in vivo Viruses 7, 1373-1390
168. Willner, P. (1984) The validity of animal models of depression Psychopharmacology (Berlin, Ger.) 83, 1-16
169. Belzung, C. and Lemoine, M. (2011) Criteria of validity for animal models of psychiatric disorders: focus on anxiety disorders and depression Biol. Mood Anxiety Disord. 1, 9
170. Fuster, J. M. (2008) The Prefrontal Cortex, 4th ed., Academic Press, London.
171. Amaral, D. G. and Lavenex, P. (2007) Hippocampal neuroanatomy, Oxford University Press, Oxford.
172. Makori, N., Tarantal, A. F., Lu, F. X., Rourke, T., Marthas, M. L., McChesney, M. B., Hendrickx, A. G., and Miller, C. J. (2003) Functional and morphological development of lymphoid tissues and immune regulatory and effector function in rhesus monkeys: Cytokine-secreting cells, immunoglobulin-secreting cells, and CD5(+) B-1 cells appear early in fetal development Clin. Diagn. Lab. Immunol. 10, 140-153
173. Fitting, S., Booze, R. M., and Mactutus, C. F. (2015) HIV-1 Proteins, Tat and gp120, Target the Developing Dopamine System Curr. HIV Res. 13, 21-42
174. Brehm, M. A., Wiles, M. V., Greiner, D. L., and Shultz, L. D. (2014) Generation of improved humanized mouse models for human infectious diseases J. Immunol. Methods 410, 3-17
175. Kranick, S. M. and Nath, A. (2012) Neurologic complications of HIV-1 infection and its treatment in the era of antiretroviral therapy Continuum (Minneapolis, MN) 18, 1319-1337
176. Demir, M. and Laywell, E. D. (2015) Neurotoxic effects of AZT on developing and adult neurogenesis Front. Neurosci. 9, 93
177. Letendre, S. L., Ellis, R. J., Ances, B. M., and McCutchan, J. A. (2010) Neurologic complications of HIV disease and their treatment Top. HIV Med. 18, 45-55
178. Etherton, M. R., Lyons, J. L., and Ard, K. L. (2015) HIV-associated Neurocognitive Disorders and Antiretroviral Therapy: Current Concepts and Controversies Curr. Infect. Dis. Rep. 17, 485
179. Akay, C., Cooper, M., Odeleye, A., Jensen, B. K., White, M. G., Vassoler, F., Gannon, P. J., Mankowski, J., Dorsey, J. L., Buch, A. M., Cross, S. A., Cook, D. R., Pena, M. M., Andersen, E. S., Christofidou-Solomidou, M., Lindl, K. A., Zink, M. C., Clements, J., Pierce, R. C., Kolson, D. L., and Jordan-Sciutto, K. L. (2014) Antiretroviral drugs induce oxidative stress and neuronal damage in the central nervous system J. Neurovirol. 20, 39-53
180. Van Rompay, K. K., Otsyula, M. G., Marthas, M. L., Miller, C. J., McChesney, M. B., and Pedersen, N. C. (1995) Immediate zidovudine treatment protects simian immunodeficiency virus-infected newborn macaques against rapid onset of AIDS Antimicrob. Agents Chemother. 39, 125-131
181. Rausch, D. M., Heyes, M., and Eiden, L. E. (1994) Effects of chronic zidovudine administration on CNS function and virus burden after perinatal SIV infection in rhesus monkeys Adv. Neuroimmunol. 4, 233-237
182. Rausch, D. M., Heyes, M. P., Murray, E. A., and Eiden, L. E. (1995) Zidovudine treatment prolongs survival and decreases virus load in the central nervous system of rhesus macaques infected perinatally with simian immunodeficiency virus J. Infect. Dis. 172, 59-69
183. Van Rompay, K. K. (2012) The use of nonhuman primate models of HIV infection for the evaluation of antiviral strategies AIDS Res. Hum. Retroviruses 28, 16-35
184. Van Rompay, K. K., Brignolo, L. L., Meyer, D. J., Jerome, C., Tarara, R., Spinner, A., Hamilton, M., Hirst, L. L., Bennett, D. R., Canfield, D. R., Dearman, T. G., Von Morgenland, W., Allen, P. C., Valverde, C., Castillo, A. B., Martin, R. B., Samii, V. F., Bendele, R., Desjardins, J., Marthas, M. L., Pedersen, N. C., and Bischofberger, N. (2004) Biological effects of short-term or prolonged administration of 9-[2-(phosphonomethoxy)propyl]adenine (tenofovir) to newborn and infant rhesus macaques Antimicrob. Agents Chemother. 48, 1469-1487
185. Kelly, K. M., Beck, S. E., Metcalf Pate, K. A., Queen, S. E., Dorsey, J. L., Adams, R. J., Avery, L. B., Hubbard, W., Tarwater, P. M., and Mankowski, J. L. (2013) Neuroprotective maraviroc monotherapy in simian immunodeficiency virus-infected macaques: reduced replicating and latent SIV in the brain AIDS 27, F21-28
186. Zink, M. C., Brice, A. K., Kelly, K. M., Queen, S. E., Gama, L., Li, M., Adams, R. J., Bartizal, C., Varrone, J., Rabi, S. A., Graham, D. R., Tarwater, P. M., Mankowski, J. L., and Clements, J. E. (2010) Simian immunodeficiency virus-infected macaques treated with highly active antiretroviral therapy have reduced central nervous system viral replication and inflammation but persistence of viral DNA J. Infect. Dis 202, 161-170
187. Zink, M. C., Uhrlaub, J., DeWitt, J., Voelker, T., Bullock, B., Mankowski, J., Tarwater, P., Clements, J., and Barber, S. (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline JAMA, J. Am. Med. Assoc. 293, 2003-2011
188. Fox, H. S., Weed, M. R., Huitron-Resendiz, S., Baig, J., Horn, T. F., Dailey, P. J., Bischofberger, N., and Henriksen, S. J. (2000) Antiviral treatment normalizes neurophysiological but not movement abnormalities in simian immunodeficiency virus-infected monkeys J. Clin. Invest. 106, 37-45
189. Venkatesan, A., Nath, A., Ming, G. L., and Song, H. (2007) Adult hippocampal neurogenesis: regulation by HIV and drugs of abuse Cell. Mol. Life Sci. 64, 2120-2132
190. Meulendyke, K. A., Queen, S. E., Engle, E. L., Shirk, E. N., Liu, J., Steiner, J. P., Nath, A., Tarwater, P. M., Graham, D. R., Mankowski, J. L., and Zink, M. C. (2014) Combination fluconazole/paroxetine treatment is neuroprotective despite ongoing neuroinflammation and viral replication in an SIV model of HIV neurological disease J. Neurovirol. 20, 591-602
191. Abers, M. S., Shandera, W. X., and Kass, J. S. (2014) Neurological and psychiatric adverse effects of antiretroviral drugs CNS Drugs 28, 131-145
192. Burke, M., Ptito, M., Ervin, F., and Palmour, R. (2010) Effects of fluoxetine on neurogenesis in fetal-ethanol exposed and sucrose-control vervet monkeys. Research Society on Alcoholism, San Antonio, Texas.
193. Rao, M. S. and Shetty, A. K. (2004) Efficacy of doublecortin as a marker to analyse the absolute number and dendritic growth of newly generated neurons in the adult dentate gyrus Eur. J. Neurosci. 19, 234-246
194. Schmued, L. C. (1990) A rapid, sensitive histochemical stain for myelin in frozen brain sections J. Histochem. Cytochem. 38, 717-720